[1]
L. S. Bezerra, M. A. O. Santos-Veloso, e M. de M. Lima, “Brentuximab Vedotin effects on prognosis of refractory and relapsed peripheral T-Cell lymphoma: a systematic review”, Rev Med Saude Brasilia, vol. 7, nº 2, jan. 2019.